Healthcare & Medical Devices Global On demand · 24-48h

Global Peritoneal Dialysis Access & Accessories Market Strategic Research Report

Global Peritoneal Dialysis Access & Accessories Market Strat…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Peritoneal Dialysis Access & Accessories Market
$3942025
7.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Straight Catheter, Pigtail-curled Catheter, Others

By Application: Acute Peritoneal Dialysis (APD), Chronic peritoneal dialysis (CPD)

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Medtronic, Fresenius, Baxter, US rental care, B.Braun, Diaverum, Nipro Corporation, Asahi Kasei, Nikkiso, Toray, WEGO group, Merit Medical, PFM Medical, AMECATH, AdvinHealthcare

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 106 pages
Market size 2025
$394
Million USD
Forecast CAGR
7.1%
2025-2032
Forecast 2032
$636.8
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Peritoneal Dialysis Access & Accessories market size is predicted to grow from US$ 394 million in 2025 to US$ 633 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.

Peritoneal Dialysis Access & Accessories refers to the ecosystem of sterile consumables and compatible components that support the full PD access pathway—from access creation and connection exchange to routine home care and complication management. It encompasses the implantable peritoneal dialysis catheter as well as transfer sets, connectors and extension lines, titanium/plastic adaptors and caps, clamps, flush/locking-related components, and exit-site securement and care supplies. The core problem this category solves is enabling safe, standardized dialysate infusion and drainage with minimal contamination exposure during frequent disconnect/reconnect cycles, while reducing the risk of peritonitis and other infections, maintaining patency, minimizing leakage or blockage, and improving usability and adherence in long-term home-based therapy. Its evolution closely tracks the shift of PD from hospital-centered care to home-centered care: early PD relied on simpler connection methods with more manual handling and less consistent infection control, but as CAPD/APD expanded and “reduced touch/reduced exposure” principles became embedded in clinical practice—supported by clearer guidelines and nursing protocols—accessories progressed from fragmented items to more systematized, traceable, and training-friendly solutions. In many markets, this has also created “platform-like” access ecosystems where catheter, transfer sets, connection systems, and care supplies are designed and validated to work together within a standardized clinical pathway. Upstream materials and components typically include medical-grade polymers (e.g., silicone, polyurethane, polypropylene, polycarbonate) for catheters, tubing, connectors, caps, and clamps; precision-molded parts and sealing structures (O-rings, valve/check mechanisms) designed for low leakage and repeated operation; sterile barrier and packaging materials (medical papers, Tyvek, blister trays, pouches, indicators, labels); textile/nonwoven and medical adhesive materials for securement and exit-site care; and, where applicable, radiopaque markers and coating/surface-treatment systems. The upstream supply chain is commonly formed by medical resin and compound suppliers, precision injection-molding and tooling specialists, silicone extrusion/assembly manufacturers, sealing component vendors, sterile packaging suppliers, and sterilization service providers.In 2025, the global production capacity of peritoneal dialysis access and accessories reached 7.0 million units, with sales volume totaling 4.726 million units. The average selling price was approximately USD 85.3 per unit, and manufacturers’ gross margins were generally in the range of 20% to 30%.

The current PD access and accessories market is defined by system-level purchasing centered on infection risk control and product bundling optimized for home usability. Hospitals and dialysis programs increasingly evaluate accessories as part of an end-to-end access quality pathway rather than interchangeable “generic” consumables, because connector integrity, repeated-use sealing performance, reduced-touch/reduced-exposure designs, workflow fit, and the availability of training and follow-up support all influence real-world peritonitis risk and patient adherence. Competition therefore tends to favor established players that offer a platform-like ecosystem—validated compatibility across catheter, transfer sets, connectors, and care supplies, reinforced by standardized training—creating strong clinical stickiness. Regional suppliers often enter through local registration agility, delivery reliability, and cost positioning, but must overcome hurdles in clinical compatibility evidence, manufacturing consistency, and hospital-level standardization. At the same time, tendering and cost containment continue to intensify, keeping the market in a constant push–pull between price pressure and outcome-driven value (lower infection and fewer complications), which elevates the importance of credible evidence and measurable workflow improvements.

Looking ahead, the category will evolve toward lower contamination exposure, higher procedural standardization, and broader digital traceability, extending deeper into home care and full-cycle chronic management. On the product side, connection and transfer systems will continue shifting toward more closed, simplified, low-error designs that maintain stable sealing performance through frequent disconnect/reconnect cycles and reduce microbial ingress risk. Accessory offerings will become more modular and scenario-specific, with clearer standard packs plus optional modules aligned to CAPD versus APD routines, patient capability differences, and variability in nursing resources—reducing unnecessary items while lowering use complexity. From a supply-chain and compliance standpoint, UDI/barcode capture and integration with hospital inventory systems will become more common, turning accessories from “consumables” into operational data entry points. Service models may expand around structured training, follow-up, infection-event review, and continuous improvement. As remote nursing and chronic-care platforms mature, accessory design will place even greater emphasis on user experience and pathway consistency to support reliable aseptic practice at home and reduce outcome variability driven by adherence.

Key drivers include healthcare systems’ dual focus on efficiency and quality in chronic disease management: expanding home dialysis, easing pressure on in-center HD capacity, and reducing complications through standardized routines are shared objectives across many regions. Clinical guidelines and quality metrics that emphasize peritonitis, access dysfunction, and readmissions also push providers to treat connection systems and care accessories as high-leverage intervention points. In addition, nursing shortages and leaner hospital operations increase the appeal of accessory bundles that are easier to train, simpler to use, and less prone to rework. Major constraints cluster around evidence thresholds, switching risk, and compliance costs: requirements for materials, sterilization, packaging validation, and change control vary by jurisdiction, and even “simple” accessory changes can trigger revalidation and regulatory burden. Clinicians often have strong pathway dependence on existing platforms, and because adverse events carry high clinical and reputational costs, platform switching typically demands substantial training and real-world data. Combined with tender-cycle uncertainty, aggressive cost pressure, and supply risks tied to critical materials and sterilization/packaging capacity, these factors can slow adoption of new entrants and delay the scaling of premium accessory solutions.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Peritoneal Dialysis Access & Accessories market?

What factors are driving Peritoneal Dialysis Access & Accessories market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Peritoneal Dialysis Access & Accessories market opportunities vary by end market size?

How does Peritoneal Dialysis Access & Accessories break out by Type, by Application?

This report presents a comprehensive overview of the global Peritoneal Dialysis Access & Accessories market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Straight Catheter
  • Pigtail-curled Catheter
  • Others

Segment by Material

  • Silicone
  • Polyurethane
  • Surface Modification Materials

Segment by Implantation Procedure

  • Percutaneous Catheter Placement
  • Laparoscopic Catheter Placement
  • Others

Segment by Application

  • Acute Peritoneal Dialysis (APD)
  • Chronic peritoneal dialysis (CPD)

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Peritoneal Dialysis Access & Accessories market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Acute Peritoneal Dialysis (APD), Chronic peritoneal dialysis (CPD) evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Peritoneal Dialysis Access & Accessories Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$394
2025
Forecast
$636.8
2032
CAGR
7.1%
2025–2032
Gebieden
5
global
Key companies
MedtronicFreseniusBaxterUS rental careB.BraunDiaverumNipro CorporationAsahi Kasei
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Straight CatheterPigtail-curled CatheterOthers
By Application
Acute Peritoneal Dialysis (APD)Chronic peritoneal dialysis (CPD)

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Straight Catheter
  • 3.1.3 Pigtail-curled Catheter
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Acute Peritoneal Dialysis (APD)
  • 4.1.3 Chronic peritoneal dialysis (CPD)
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Medtronic
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Fresenius
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Baxter
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 US rental care
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 B.Braun
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Diaverum
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Nipro Corporation
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Asahi Kasei
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Nikkiso
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Toray
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 WEGO group
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Merit Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 PFM Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 AMECATH
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 AdvinHealthcare
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Peritoneal Dialysis Access & Accessories market size?
The global Peritoneal Dialysis Access & Accessories market is estimated at US$ 394 million in 2025 (base year) and is projected to reach US$ 633 million by 2032.
What growth rate is expected for the Peritoneal Dialysis Access & Accessories market through 2032?
The market is expected to grow at a CAGR of 7.1% from 2026 to 2032, expanding from US$ 394 million in 2025 to US$ 633 million in 2032, roughly 1.6 times its base-year value.
How is Peritoneal Dialysis Access & Accessories defined?
Peritoneal Dialysis Access & Accessories refers to the ecosystem of sterile consumables and compatible components that support the full PD access pathway—from access creation and connection exchange to routine home care and complication management. It encompasses the implantable peritoneal dialysis catheter as well as transfer sets, connectors and extension lines, titanium/plastic adaptors and caps, clamps, flush/locking-related components, and exit-site securement and care supplies.
What are the main segments of the Peritoneal Dialysis Access & Accessories market by type?
By type, the market is segmented into Straight Catheter, Pigtail-curled Catheter and Others.
Which applications drive demand in the Peritoneal Dialysis Access & Accessories market?
Key applications covered include Acute Peritoneal Dialysis (APD) and Chronic peritoneal dialysis (CPD).
Who are the key players in the Peritoneal Dialysis Access & Accessories market?
Key players profiled include Medtronic, Fresenius, Baxter, US rental care, B.Braun, Diaverum, Nipro Corporation and Asahi Kasei, among 15 companies covered in total.
Which regions and countries are covered for Peritoneal Dialysis Access & Accessories?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Peritoneal Dialysis Access & Accessories market?
At the same time, tendering and cost containment continue to intensify, keeping the market in a constant push–pull between price pressure and outcome-driven value (lower infection and fewer complications), which elevates the importance of credible evidence and measurable workflow improvements.
What challenges does the Peritoneal Dialysis Access & Accessories market face?
Major constraints cluster around evidence thresholds, switching risk, and compliance costs: requirements for materials, sterilization, packaging validation, and change control vary by jurisdiction, and even “simple” accessory changes can trigger revalidation and regulatory burden.
Who should buy the Peritoneal Dialysis Access & Accessories market report?
The report is intended for manufacturers and solution providers, distributors and end users in Acute Peritoneal Dialysis (APD) and Chronic peritoneal dialysis (CPD), investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Peritoneal Dialysis Access & Accessories market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.